Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Syuichi Ota"'
Autor:
Iori Nakamura, Haruhi Ida, Mayu Yabuta, Wataru Kashiwa, Maho Tsukamoto, Shigeki Sato, Syuichi Ota, Naoki Kobayashi, Hiromi Masauzi, Kazunori Okada, Sanae Kaga, Keiko Miwa, Hiroshi Kanai, Nobuo Masauzi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Differential bone marrow (BM) cell counting is an important test for the diagnosis of various hematological diseases. However, it is difficult to accurately classify BM cells due to non-uniformity and the lack of reproducibility of different
Externí odkaz:
https://doaj.org/article/5f8bfd3d6fe04b0687b7307cee0d798e
Autor:
Hajime, Nomura, Masahiko, Okamura, Atsuhiko, Sumii, Kunihiko, Tsuboi, You, Mizukami, Syuichi, Ota, Yukihito, Adachi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(6)
A 77-year-old man was diagnosed with gastric cancer with synchronous single liver metastasis and portal vein thrombus. His HER2 immunohistochemistry tumor score was 3+; therefore, we administered trastuzumab plus capecitabine plus cisplatin. After 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::060ce2d64f68880a86fd71dd1de3efd4
https://pubmed.ncbi.nlm.nih.gov/28698446
https://pubmed.ncbi.nlm.nih.gov/28698446
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 61(7)
Primary tumors of the seminal vesicles are extremely rare. There have been 25 reports of this tumor from overseas and most cases are cystadenoma. We report a case of seminal vesicle cystadenoma in a 70-year-old man who presented with lower abdominal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36954e086bf545b0506bbef0fdcef0bc
https://pubmed.ncbi.nlm.nih.gov/26278217
https://pubmed.ncbi.nlm.nih.gov/26278217
Autor:
Rena, Morita, Satoshi, Hashino, Susumu, Sogabe, Masayoshi, Dazai, Masahiro, Onozawa, Koh, Izumiyama, Takeshi, Kondo, Syuichi, Ota, Sumiko, Kobayashi, Masahiro, Imamura, Masahiro, Asaka
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 45(10)
Imatinib mesylate (imatinib) has shown significant effects in patients with chronic myelogenous leukemia. However, hematological toxicity often occurs and requires dosage reduction or discontinuation of imatinib treatment. A patient with chronic myel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a5a9d856eb2bc7ea339ba37b3aaafd2f
https://pubmed.ncbi.nlm.nih.gov/15553045
https://pubmed.ncbi.nlm.nih.gov/15553045
Autor:
Hideaki Takayama, Masashi Sakamoto, Mitsuo Kusano, Hiroshi Ishii, Shigeki Tanaka, Yoshiko Onizuka, Keiji Mitamura, Akihiro Nakamura, Syuichi Ota
Publikováno v:
Internal medicine (Tokyo, Japan). 37(10)
A 77-year-old female was admitted to our hospital because of pyrexia and a right retroperitoneal mass. Leukocytosis and other inflammatory findings were noted. Bone-marrow aspiration revealed hypercellularity with no malignant cells. An additional ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3baa62a497f78b58cc37881524cda329
https://pubmed.ncbi.nlm.nih.gov/9840715
https://pubmed.ncbi.nlm.nih.gov/9840715